Glenmede Trust CO Na Spectrum Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.38 - $5.14 $9,545 - $14,515	-2,824 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $418 - $686	140 Added 5.22%	2,824 $11,000
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $2,253 - $3,609	1,068 Added 66.09%	2,684 $9,000
Q4 2019 Feb 12, 2020	BUY	$3.5 - $10.35 $3,783 - $11,188	1,081 Added 202.06%	1,616 $5,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $1,279 - $1,765	182 Added 51.56%	535 $4,000
Q1 2019 May 14, 2019	SELL	$9.08 - $11.84 $7,899 - $10,300	-870 Reduced 71.14%	353 $3,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $21,732 - $57,782	-3,401 Reduced 73.55%	1,223 $10,000
Q3 2018 Nov 15, 2018	BUY	$16.52 - $24.82 $26,514 - $39,836	1,605 Added 53.16%	4,624 $76,000
Q2 2018 Nov 05, 2018	SELL	$14.31 - $21.75 $5,724 - $8,700	-400 Reduced 11.7%	3,019 $63,000
Q2 2018 Aug 15, 2018	BUY	$14.31 - $21.75 $48,925 - $74,363	3,419 New	3,419 $71,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.